Saturday, October 3, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
News articleCB Insights

The AI agent market map

View original at cbinsights.com
CB Insights - Enterprise Ai Title: The AI agent market map Date: 2025-11-10 20:14 Source: https://www.cbinsights.com/research/ai-agent-market-map-2025/ <p>The AI agent moment is reshaping enterprise software.</p> <p>Since <a href="https://www.cbinsights.com/research/ai-agent-market-map/">our last mapping in March 2025<…
Opening lines of the source · CB Insights · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Horizontal AI agent startups outnumber verticalized solutions nearly 2-to-1 in the landscape.

    80% confidence
  • Agentic solutions have become a leading acquisition target for enterprise software incumbents.

    80% confidence
  • AI agent startups focused on cybersecurity operations are most primed to exit based on average CB Insights M&A probability scores.

    80% confidence
  • The private AI agent market is moving towards greater specialization, with industry-specific solutions surging since March 2025.

    80% confidence
  • Since March 2025, the AI agent landscape has exploded from roughly 300 players to thousands as tech companies race to launch AI agent offerings.

    80% confidence
  • AI-related cybersecurity M&A has already reached record levels in 2025.

    80% confidence
  • The healthcare and life sciences AI agent category grew from 7 companies in March 2025 to 47 companies in the November 2025 map iteration.

    80% confidence
  • Emerging startups are betting that highly regulated industries will favor specialized AI agent solutions over horizontal tools.

    80% confidence
  • 1 in 5 new unicorns ($1B+ valuation) are now developing AI agents.

    80% confidence
  • AI agents combine reasoning, memory, tool use, and planning capabilities.

    80% confidence
  • The software development AI agent market is the most crowded on the map, reflecting the value agents bring to well-defined workflows and testable environments.

    80% confidence
  • The coding AI agent market is facing challenges as reasoning models drive higher inference costs, previewing pricing pressures other agent categories will face.

    80% confidence
  • The top 20 AI agent revenue leaders average just 3.8 years old, with software development leading revenue activity featuring 6 coding agents.

    80% confidence
  • Nullify and Strike Ready top the cybersecurity acquisition probability list with 70%+ probability of getting acquired within the next two years.

    80% confidence

Cited in these Via News reports

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Pharma Pipeline Catalysts and M&A Heat Up as AI-Designed Drugs Enter the Clinic
Late-September 2026 brought a dense run of clinical readouts: Novo Nordisk's CagriSema data at EASD, Lilly's ADtouch results for EBGLYSS, and Merck's tulisokibart Phase 2b result. Lilly's $2.9B Merida Biosciences acquisition and the 2026-11-14 FDA PDUFA date for ivonescimab sit alongside these as the main deal and regulatory events. AI-designed drugs such as rentosertib, and speculative AI-linked trial ventures such as QAIAx, are moving from hype toward clinical validation. Broader AI-sector regulatory and legal friction (Tesla Cybercab probe, xAI Minnesota ruling, OpenAI lawsuits) shows rising scrutiny that could spill into AI-driven healthcare.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
Apple Inc.
The observation date (2025-12-27) precedes Q1 2026, making it logically impossible to have actual Q1 2026 cash data at that point. Q1 2026 would not end until March 31, 2026. Additionally, the magnitude of the difference ($45.3B vs $132.42) is implausibly large even as a normal quarterly change for Apple. While different fiscal periods can show different values, the timing relationship here suggests a data integrity issue rather than legitimate period-over-period variation.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,985
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,985 facts checked against source5,329 source documents archived
Query this data → isubstrate.com